Syros Pharmaceuticals' Series A Round

Syros Pharmaceuticals raised a round of funding on April 11, 2013.

Syros Pharmaceuticals is a therapeutics company working in gene control to develop the treatment of cancer and other diseases. Syros' platform identifies the master switches for disease genes, opening…

Articles about Syros Pharmaceuticals' Series A Round: